· Volume surge · RGC
Regencell Bioscience Holdings Ltd (RGC) volume swells as weekly selling accelerates
The healthcare stock’s reversal is being confirmed by heavier turnover and weak momentum readings in weekly context.
Regencell Bioscience Holdings Ltd (RGC) closed the latest week at $6.48, falling 46.0% in the weekly market data. The 52-week weekly price path shows the move as part of a deeper reset rather than a live intraday swing.
Turnover rose to 2.19 million shares, about 2.9 times the 13-week average. Market Dynamics showed pressure at -1.46, while Relative Strength stood at -72.5, leaving the evidence firmly weak despite the stock trading below indicated fair value of about $8.00.